[123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration. (Q51371295)

From Wikidata

Jump to navigation Jump to search

scientific article published in November 2000

[123I]?-CIT spect in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration

Language	Label	Description	Also known as
English	[123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration.	scientific article published in November 2000	[123I]?-CIT spect in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/11104200

[123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/11104200

multiple system atrophy

1 reference

based on heuristic

inferred from title

progressive supranuclear palsy

1 reference

based on heuristic

inferred from title

author name string

Pirker W

1

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/11104200

Asenbaum S

2

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/11104200

Bencsits G

3

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/11104200

Prayer D

4

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/11104200

Gerschlager W

5

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/11104200

Deecke L

6

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/11104200

Brücke T

7

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/11104200

language of work or name

0 references

publication date

1 November 2000

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/11104200

Movement Disorders

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/11104200

15

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/11104200

6

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/11104200

1158-1167

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/11104200

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

21 January 2018

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

21 January 2018

Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

21 January 2018

Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

21 January 2018

Initial experience with single-photon emission tomography using iodine-123-labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl) tropane in human brain.

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

21 January 2018

SPECT imaging of dopamine and serotonin transporters with [123I]?-CIT. Binding kinetics in the human brain

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

21 January 2018

Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

21 January 2018

[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

21 January 2018

Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

21 January 2018

[123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: high-affinity SPECT radiotracer of monoamine reuptake sites in brain

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

21 January 2018

Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

21 January 2018

Parkinsonism: onset, progression, and mortality

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

21 January 2018

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

21 January 2018

High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

21 January 2018

Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjects.

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

21 January 2018

[125I]RTI-55: a potent ligand for dopamine transporters

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

21 January 2018

SPECT imaging of dopamine and serotonin transporters with [123I]β‐CIT: Pharmacological characterization of brain uptake in nonhuman primates

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

21 January 2018

The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

21 January 2018

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

21 January 2018

Progressive supranuclear palsy: relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

21 January 2018

Dopaminergic and cholinergic lesions in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

21 January 2018

Differential distribution of striatal [123I]beta-CIT in Parkinson's disease and progressive supranuclear palsy, evaluated with single-photon emission tomography.

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

21 January 2018

Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [123I]beta-CIT.

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

21 January 2018

Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

21 January 2018

?-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1158%3A%3AAID-MDS1015%3E3.0.CO%3B2-0

21 January 2018

Identifiers

10.1002/1531-8257(200011)15:6<1158::AID-MDS1015>3.0.CO;2-0

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/11104200

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/11104200

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51371295&oldid=1508007805"